WallStreetZenWallStreetZen

NASDAQ: PRTK
Paratek Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PRTK

Based on 1 analyst offering 12 month price targets for Paratek Pharmaceuticals Inc.
Min Forecast
$20.00+1,198.7%
Avg Forecast
$20.00+1,198.7%
Max Forecast
$20.00+1,198.7%

Should I buy or sell PRTK stock?

Based on 1 analyst offering ratings for Paratek Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PRTK stock forecasts and price targets.

PRTK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 7%
94
BuyMaintains$20.00+1,198.70%2022-05-06

1 of 1

Forecast return on equity

Is PRTK forecast to generate an efficient return?
Company
N/A
Industry
-0.1%
Market
29.08%

Forecast return on assets

Is PRTK forecast to generate an efficient return on assets?
Company
N/A
Industry
0.01%

PRTK earnings per share forecast

What is PRTK's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$0.48
Avg 2 year Forecast
$1.88
Avg 3 year Forecast
$2.06

PRTK revenue forecast

What is PRTK's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$254.8M+59.01%
Avg 2 year Forecast
$351.5M+119.33%
Avg 3 year Forecast
$365.4M+127.97%
PRTK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PRTK revenue growth forecast

How is PRTK forecast to perform vs Biotechnology companies and vs the US market?
Company
33.25%
Industry
41.6%
Market
8.82%
PRTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PRTK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PRTK vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PRTK$1.54$20.00+1,198.70%Buy
LBPH$3.84$19.33+403.46%Strong Buy
ORMP$2.23$30.00+1,245.29%Strong Buy
ATOS$0.69$4.00+479.71%Strong Buy
TALS$2.09$5.67+171.15%Hold
View Top Biotech Stocks

Paratek Pharmaceuticals Stock Forecast FAQ

Is Paratek Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PRTK) stock is to Buy PRTK stock.

Out of 1 analyst, 0 (0%) are recommending PRTK as a Strong Buy, 1 (100%) are recommending PRTK as a Buy, 0 (0%) are recommending PRTK as a Hold, 0 (0%) are recommending PRTK as a Sell, and 0 (0%) are recommending PRTK as a Strong Sell.

If you're new to stock investing, here's how to buy Paratek Pharmaceuticals stock.

What is PRTK's earnings growth forecast for 2023-2025?

(NASDAQ: PRTK) Paratek Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.18%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.45%.

Paratek Pharmaceuticals's earnings in 2023 is -$63,566,000.On average, 2 Wall Street analysts forecast PRTK's earnings for 2023 to be $27,487,339, with the lowest PRTK earnings forecast at -$24,051,421, and the highest PRTK earnings forecast at $78,453,446. On average, 2 Wall Street analysts forecast PRTK's earnings for 2024 to be $107,658,743, with the lowest PRTK earnings forecast at $41,231,008, and the highest PRTK earnings forecast at $174,086,479.

In 2025, PRTK is forecast to generate $117,966,495 in earnings, with the lowest earnings forecast at $34,931,826 and the highest earnings forecast at $200,428,512.

What is PRTK's revenue growth forecast for 2023-2025?

(NASDAQ: PRTK) Paratek Pharmaceuticals's forecast annual revenue growth rate of 33.25% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 41.6%, and while it is forecast to beat the US market's average forecast revenue growth rate of 8.82%.

Paratek Pharmaceuticals's revenue in 2023 is $160,268,000.On average, 2 Wall Street analysts forecast PRTK's revenue for 2023 to be $14,593,772,575, with the lowest PRTK revenue forecast at $11,162,150,132, and the highest PRTK revenue forecast at $18,025,395,019. On average, 2 Wall Street analysts forecast PRTK's revenue for 2024 to be $20,129,608,063, with the lowest PRTK revenue forecast at $17,124,612,023, and the highest PRTK revenue forecast at $23,134,604,103.

In 2025, PRTK is forecast to generate $20,922,159,663 in revenue, with the lowest revenue forecast at $16,693,404,396 and the highest revenue forecast at $25,150,914,929.

What is PRTK's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: PRTK) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.01%.

What is PRTK's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PRTK price target, the average PRTK price target is $20.00, with the highest PRTK stock price forecast at $20.00 and the lowest PRTK stock price forecast at $20.00.

The Wall Street analyst predicted that Paratek Pharmaceuticals's share price could reach $20.00 by May 6, 2023. The average Paratek Pharmaceuticals stock price prediction forecasts a potential upside of 1,198.7% from the current PRTK share price of $1.54.

What is PRTK's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: PRTK) Paratek Pharmaceuticals's current Earnings Per Share (EPS) is -$1.17. On average, analysts forecast that PRTK's EPS will be $0.48 for 2023, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at $1.37. On average, analysts forecast that PRTK's EPS will be $1.88 for 2024, with the lowest EPS forecast at $0.72, and the highest EPS forecast at $3.04. In 2025, PRTK's EPS is forecast to hit $2.06 (min: $0.61, max: $3.50).

What is PRTK's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: PRTK) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.